810 related articles for article (PubMed ID: 36375174)
1. Pharmacological interventions for people with borderline personality disorder.
Stoffers-Winterling JM; Storebø OJ; Pereira Ribeiro J; Kongerslev MT; Völlm BA; Mattivi JT; Faltinsen E; Todorovac A; Jørgensen MS; Callesen HE; Sales CP; Schaug JP; Simonsen E; Lieb K
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD012956. PubMed ID: 36375174
[TBL] [Abstract][Full Text] [Related]
2. Psychological therapies for people with borderline personality disorder.
Storebø OJ; Stoffers-Winterling JM; Völlm BA; Kongerslev MT; Mattivi JT; Jørgensen MS; Faltinsen E; Todorovac A; Sales CP; Callesen HE; Lieb K; Simonsen E
Cochrane Database Syst Rev; 2020 May; 5(5):CD012955. PubMed ID: 32368793
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological interventions for the treatment of disordered and problem gambling.
Dowling N; Merkouris S; Lubman D; Thomas S; Bowden-Jones H; Cowlishaw S
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD008936. PubMed ID: 36130734
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).
Iffland M; Livingstone N; Jorgensen M; Hazell P; Gillies D
Cochrane Database Syst Rev; 2023 Oct; 10(10):CD011769. PubMed ID: 37811711
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for somatoform disorders in adults.
Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
[TBL] [Abstract][Full Text] [Related]
7. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011006. PubMed ID: 29683474
[TBL] [Abstract][Full Text] [Related]
8. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD008559. PubMed ID: 28791693
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological interventions for borderline personality disorder.
Stoffers J; Völlm BA; Rücker G; Timmer A; Huband N; Lieb K
Cochrane Database Syst Rev; 2010 Jun; (6):CD005653. PubMed ID: 20556762
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological interventions for antisocial personality disorder.
Khalifa NR; Gibbon S; Völlm BA; Cheung NH; McCarthy L
Cochrane Database Syst Rev; 2020 Sep; 9(9):CD007667. PubMed ID: 32880105
[TBL] [Abstract][Full Text] [Related]
11. Methylphenidate for children and adolescents with attention deficit hyperactivity disorder (ADHD).
Storebø OJ; Storm MRO; Pereira Ribeiro J; Skoog M; Groth C; Callesen HE; Schaug JP; Darling Rasmussen P; Huus CL; Zwi M; Kirubakaran R; Simonsen E; Gluud C
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD009885. PubMed ID: 36971690
[TBL] [Abstract][Full Text] [Related]
12. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
13. Acupuncture for depression.
Smith CA; Armour M; Lee MS; Wang LQ; Hay PJ
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD004046. PubMed ID: 29502347
[TBL] [Abstract][Full Text] [Related]
14. Antidepressants for the treatment of depression in people with cancer.
Ostuzzi G; Matcham F; Dauchy S; Barbui C; Hotopf M
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD011006. PubMed ID: 26029972
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological, psychological, and non-invasive brain stimulation interventions for treating depression after stroke.
Allida S; Cox KL; Hsieh CF; Lang H; House A; Hackett ML
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD003437. PubMed ID: 31989584
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia.
Mühlbauer V; Möhler R; Dichter MN; Zuidema SU; Köpke S; Luijendijk HJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD013304. PubMed ID: 34918337
[TBL] [Abstract][Full Text] [Related]
17. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
18. Extended-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Boesen K; Paludan-Müller AS; Gøtzsche PC; Jørgensen KJ
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD012857. PubMed ID: 35201607
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants for the treatment of depression in people with cancer.
Vita G; Compri B; Matcham F; Barbui C; Ostuzzi G
Cochrane Database Syst Rev; 2023 Mar; 3(3):CD011006. PubMed ID: 36999619
[TBL] [Abstract][Full Text] [Related]
20. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]